Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEATE: Urine Alkalinization for CIN Prevention
NCT02980003Phase 3Completed
- Sponsor
- Università degli Studi Gabriele d'Annunzio Chieti e Pescara
- Start
- Mar 2015
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of sodium bicarbonate in contrast-induced nephropathy (CIN) (3 arms), sponsored by Università degli Studi Gabriele d'Annunzio Chieti e Pescara. Primary endpoint: Incidence of CIN according to urine alkalinization achieved immediately before angiography at 48 hours. Started Mar 2015; status: completed.
02
Drugs
sodium bicarbonate
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on NCT02980003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02980003.